Growth Metrics

Standard Biotools (LAB) Cash from Operations (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Standard Biotools 448.37 Mn -6.80 Mn 11.31 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -3,815.71%
Dec 31, 2025 94.64%
Sep 30, 2025 -7.42%
Jun 30, 2025 31.75%
Mar 31, 2025 -115.40%
Dec 31, 2024 49.55%
Sep 30, 2024 28.63%
Jun 30, 2024 37.50%
Mar 31, 2024 -344.32%
Dec 31, 2023 -23.21%
Sep 30, 2023 -22.33%
Jun 30, 2023 -9.95%
Mar 31, 2023 55.76%
Dec 31, 2022 22.06%
Sep 30, 2022 17.93%
Jun 30, 2022 -92.35%
Sep 30, 2021 -34.44%
Jun 30, 2021 -113.67%
Mar 31, 2021 -245.59%
Dec 31, 2020 18.83%
Sep 30, 2020 -64.84%
Jun 30, 2020 35.04%
Mar 31, 2020 22.18%
Dec 31, 2019 -21.35%
Sep 30, 2019 9.28%
Jun 30, 2019 75.10%
Mar 31, 2019 -3,055.17%
Dec 31, 2018 84.30%
Sep 30, 2018 5.99%
Jun 30, 2018 73.28%
Mar 31, 2018 -2,547.20%
Dec 31, 2017 108.28%
Sep 30, 2017 3.73%
Jun 30, 2017 2.33%
Mar 31, 2017 20.89%
Dec 31, 2016 19.09%
Sep 30, 2016 -80.34%
Jun 30, 2016 5.62%
Mar 31, 2016 -76.93%
Dec 31, 2015 65.32%
Sep 30, 2015 -62.22%
Jun 30, 2015 20.11%
Mar 31, 2015 -178.01%
Dec 31, 2014 60.23%
Sep 30, 2014 -2,940.71%
Jun 30, 2014 102.96%
Mar 31, 2014 -425.73%
Dec 31, 2013 347.55%
Sep 30, 2013 50.40%
Jun 30, 2013 -198.30%
Mar 31, 2013 74.74%
Dec 31, 2012 -4.89%
Sep 30, 2012 16.60%
Jun 30, 2012 39.79%
Mar 31, 2012 -194.59%
Dec 31, 2011 5.21%
Sep 30, 2011 79.63%
Jun 30, 2011 -850.28%
Mar 31, 2011 45.64%
Dec 31, 2010 29.78%